图片: | |
---|---|
名称: | |
描述: | |
姓 名: | ××× | 性别: | 年龄: | ||
标本名称: | |||||
简要病史: | |||||
肉眼检查: |
I heard that open biopsy is the initial prodecure for breast palpable breast mass lesions in most of our hospitals. Can you write down the initial or first procedure used for these women in your hospitals?
A. Fine needle aspiration biopsy
B. Core needle biopsy
C. Open biopsy
Hospitals in China
In most situation or in most cases.
Also what is the initial procedure for most non-palpable breast lesions.
Palpable lesions: one of A, B, C
Non-palpable lesions:one of A, B, C.
Thanks,
cz
It varies depending on the breast surgeons preference. One breast surgeon I worked closely with will do the following:
For palpable masses, if she strongly suspects cancer, she would do core biopsy direct in her office, becaue she would like to know the ER/PR/ her 2 fast. Although we can do these ancillary studies with FNA cell block or direct smears, sometimes the IHC is not successful due to lack of enough cells and it takes longer times than core biopsy to know the results. If we use direct smears for IHC, we have to lift up the cover slip, de-stain and restain.
If she is not strongly suspect cancer, but cannot exclude it, she would ask us to do a FNA as the initial work up.
For non-palpable lesions, she varies depending upon radiographic findings, sometimes core biopsies directly, sometimes FNA first.
Dear Dr. Zhao,
Nice meeting you and communicating with you at this wonderful platform. I will not attend the USCAP conference at boston this year because that specific week was marked off by one of my colleagues. Our staffing status cannot allow 2 pathologists taking off at any giving time. But I will go to Boston to see my old friends, becaue my home is only 2 hours away. I will be very delighted to see you there. I will probably go to the Wash U Alumini reception, i think on Saturday night, right?
A. Fine needle aspiration biopsy A、细针吸活检,
B. Core needle biopsy B、粗针活检
C. Open biopsy C、手术切开除活检,
mingfuyu 帖子:It varies depending on the breast surgeons preference.如何处理取决于外科医生的不同选择, One breast surgeon I worked closely with will do the following:与我有密切接触的外科医生会处理如下:For palpable masses, if she strongly suspects cancer, she would do core biopsy direct in her office,如果摸到乳腺包块非常可疑癌,她会做粗针活检。 becaue she would like to know the ER/PR/ her 2 fast.主要是她想更快的知道ER/PR/ her 2结果。 Although we can do these ancillary studies with FNA cell block or direct smears, sometimes the IHC is not successful due to lack of enough cells and it takes longer times than core biopsy to know the results. 如果我们做传统的细针吸活检,取细胞块或直接细胞涂片,做出来的免疫组化不一定能满意,要想知道免疫组化结果会非常慢。 If we use direct smears for IHC, we have to lift up the cover slip, de-stain and restain.如果用涂片做免疫组化,必须去掉盖玻片,需要去染和复染。If she is not strongly suspect cancer, but cannot exclude it, she would ask us to do a FNA as the initial work up.如果外科医生不是特别怀疑癌,也不排除癌的话,我们可以第一步先做细针吸活检,For non-palpable lesions, she varies depending upon radiographic findings, sometimes core biopsies directly, sometimes FNA first.摸不清楚的包块,如何处理取决于放射科医生的意见,有时粗针,有时细针吸活检。 None of our surgeons would do open biopsy directly for breast masses, to my experience..在我的印象里,我们医院没有一例外科医生直接手术切开取活检。
这是一个非常好的帖子,尽管如此简单,大家没有太多的回帖,主要是不知道什么是最标准的处理方法。我们医院也是因人而异,比如一个病人摸起来非常象乳腺癌,就直接手术,手术台上做冰冻切片,证实癌直接做大手术,保乳的人非常少,有些癌很小我让外科医生保乳,他们问病人,病人坚决不保,也就不保了。还有些特殊类型的癌,如胶样癌,小管癌,我坚持让病人保乳,也是费半天劲,不落好。有时也保不住乳腺。
如果摸的包块不很象癌,就做细针吸活检细胞学诊断,如果有问题再做手术大切,没有做粗针活检的习惯。
如果是摸不清的乳腺包块,基本是都是观察, 不做病理检查。
有一个医生可疑乳癌,喜欢切开取活检,我说他好几次,现在也没有这样的人了。 请赵老师讲一讲粗针活检的优点。也想问mingfuyu 老师,为什么要快速知道PR ER HER2的结果?一般内分泌治疗都是在化疗放疗半年后,早知道免疫组化结果有什么治疗用途?
译上楼:To answer 月新's questions: 回答月新问题:Overall, both FNAB and CNB can provide excellent opportunity to avoid unnecessary open biopsies. 粗针和细针活检都有优点,都可以避免不必要的手术切开活检。No single procedure is good for everyone. 没有一个方法能适合所有的人。Goal must be to choose the right procedure for every patient who puts her trust in our hands. 目的是选择一个合适的方法,Should consider the cost, patients' comfort (physical and psychological).同时也考虑患者的费用,心理,身体等等。FNA advantages:细针活检优点:Cost effective, Economic value 经济实用,Less pain 痛苦小,Speed and psychosocial value 出结果快,心理容易接受。Reliable and accurate 可靠性准确性也好。Flexibility in various clinical settings开展场地也随意。Integral part of any mass breast screening program 任何查到的乳腺包块都可以开展。Reduction in the surgical excision rate in benign breast disease可以明显减少良性乳腺病的手术切除机会。FNA disadvantage细针的缺点:Difficult to separate DCIS from invasive cancer 不能区别导管原位癌和浸润癌。-False positive and false negative 假阳性假阴性,-Inability to make a diagnosis of papillary lesion 不能做出乳头状病变的病理诊断。-Cannot identify lymph-vascular invasion不能区别淋巴和血管浸润。Advantage of core needle biopsy:粗针的优点:are the above disadvantage of FNA even though the sensitivity and specifity are similar.与细针相比准确性差不多。In addition, FNA interpretaion needs well trained cytopathologists.细针穿刺诊断医生训练要求高点, CNB is relative easy to interpretate.粗针诊断一般的病理医生都行。Good in non-palpable breast mass摸不清包块用粗针效果好。Disadvantage of Core biopsy 粗针的缺点。More expensive than FNA比细针贵的多,花费用高,More tranmatic for patients 创伤大。Longer time病人等时间长。Possibility of seeding the biopsy tract?有可能有活检口的肿瘤种殖。Open biopsy should not be used as the initial procedure in most breast lesions even though it may be used in most hospitals in China.虽然在中国多数医院仍然是以手术切开活检为主,但是实际上手术切开活检不应该再被用于大多数的乳腺肿瘤,不能做为乳腺肿块的活检首选, It is too bad.效果太差, Open biopsy with fozen was used as initial procedure for breast mass 30 years ago in the US.手术切开活检,术中冰冻切片确诊,这是美国30年前的老方法。I have not any intention to discuss this topic here.关于这点不在此展开讨论,也没有必要。 But I have to based on the requirement of Dr. 月新.但是根据月新的提问我说了几句。 However there is few persons in
很有意思的讨论!美国都讲快,快,快,快出诊断,快出IHC结果,有时并不知道为什么?比如我工作过的医院当天出50%以上的活检报告,恶性诊断有时显微镜边就报告给临床医生了。 I think it is mostly to prove to our clinicians, clincians prove to their patients, our efficiency and commitmemt to prompt and quality patient care.
FNA is really fast. We give on-site diagnosis sometimes. It means the patients get a pathologic report during their doctors' visit.
美国妇女有不少保乳的。乳腺全切不很多,很多是包块切除加前哨淋巴结(lumpectomy with sentinel lymph node).现在乳腺癌很多都是早期诊断。
我们这儿啥都是快快快,有时并不知道为啥。但我并不觉得这儿的tamoxifen and herceptin一定是半年之后。美国刚出了乳腺癌的诊断治疗guideline,上班去查查。If you really want to know why the doctors want to know the receptors/Her2 fast, i have to ask them. With breast core biopsy, we report H&E diagnose the second day and ER/PR/Her2 the day after, that is day 3 of the biopsy.
When we call the clinicians to tell them a malignant diagnosis next to the microsope, we are 120% sure about the diagnoses. We never put our reputation or patients' benefit in jeopardy. So, please relax, we are very cautious, we cannot afford to make mistakes!
We practice with guidelines, pathologists as well as clinicians. But we also put our training, experience and personal preference into our work. Some doctors are just forever in a big hurry, want to know everything right away. If we can accomodate them, we do, they are our clients. One breast surgeon i worked with promises her patients FNA diagnosis after 4 pm on the day of office visit. We try our best to report to her before 4 pm, of course, always by phone.
For autopsies, we have to give preliminary diagnoses within 24 hours after the autopsy. Patients are dead already, why are we in a hurry to give a report? I don't know, but i do. I believe that is the CAP (college of american pathologists) guideline.. We also have to give a complete report of autopsy in 30 days.